High-quality evidence helps prevent infection after miscarriage surgery

New international guidelines on how to provide treatment for women having miscarriage surgery are needed, says BHP founder member the University of Birmingham, following a large-scale international trial. Published in the New England Journal of Medicine (NEJM) today (March 13th) , the trial involved thousands of women at hospitals across four low- and middle-income countries. The team’s aim was to find out if the risk of pelvic infection could be reduced by giving women a single, … Continue reading “High-quality evidence helps prevent infection after miscarriage surgery”

Dental students to train on ‘lifelike’ mouth models

Dental models with the tactile qualities of real mouths will be used to train the next generation of dentists thanks to new research carried out in collaboration with BHP founder member the University of Birmingham. A joint project by Dr Michael Milward and Professor Paul Cooper at the University’s School of Dentistry and PhD candidate Richard Arm of Nottingham Trent University (NTU) will allow student dentists to experience and learn how it feels to use … Continue reading “Dental students to train on ‘lifelike’ mouth models”

HRH The Duke of Sussex visits the world’s first conflict wound research centre

HRH The Duke of Sussex met scientists and clinical experts from BHP founder members the University of Birmingham and University Hospitals Birmingham NHS Foundation Trust during a visit to the world’s first specialist military and civilian wound research centre. His Royal Highness visited the Scar Free Foundation Centre for Conflict Wound Research, a ground-breaking national facility based at Queen Elizabeth Hospital Birmingham, which aims to minimise the psychological and physical impact of scarring and limb … Continue reading “HRH The Duke of Sussex visits the world’s first conflict wound research centre”

Ovarian cancer: improving survival rates

“Research published during the last few years has investigated the effectiveness of a new approach involving giving some chemotherapy, then performing surgery, followed by completing chemotherapy.”  Professor Sean Kehoe, Lawson Tait Professor of Gynaecological Cancer Ovarian cancer affects around 7,000 women each year in the UK, a figure expected to rise to 10,000 by 2035.  It is the most common type of cancer in women over the age of 50 years, but some rarer types … Continue reading “Ovarian cancer: improving survival rates”

De-risking medical innovation with MD-TEC

MD-TEC, our Medical Devices Testing & Evaluation Centre, recently came together with a host of local medtech and life sciences organisations to showcase the unique insight, expertise and assistance the team can offer. The MD-TEC Connect event included talks from industry experts; 1:1 advice sessions, and presentations on the Centre’s ability to bring medical devices to market quickly and at reduced cost. One of of the presenters was Keith Fawdington, Managing Director of Uvamed Ltd, … Continue reading “De-risking medical innovation with MD-TEC”